Actelion is a startup based in Switzerland, most recent round Acquired, 3 tracked investors.
Actelion is a startup founded in 1997 based in Switzerland. Actelion has been acquired. Brouky records 3 investors associated with the company.
Actelion was a Swiss biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for pulmonary arterial hypertension (PAH) and other rare diseases. It was acquired by Johnson & Johnson in 2017.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.